Intel Commits $50 Million with Pandemic Response Technology Initiative to Combat Coronavirus
What’s New: Today, Intel is pledging an additional $50 million in a pandemic response technology initiative to combat the coronavirus through accelerating access to technology at the point of patient care, speeding scientific research and ensuring access to online learning for students. Included in Intel’s effort is an additional innovation fund for requests where access to Intel expertise and resources can have immediate impact. This is in addition to prior announcements of $10 million in donations that are supporting local communities during this critical time.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200407005209/en/
Handeln Sie Ihre Einschätzung zu Intel Corporation!
Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.
Intel is committed to accelerating access to technology that can combat the current COVID-19 pandemic and enable new technology and scientific discovery that better prepares society for future crises. (Credit: Intel Corporation)
“The world faces an enormous challenge in fighting COVID-19. Intel is committed to accelerating access to technology that can combat the current pandemic and enable new technology and scientific
discovery that better prepares society for future crises. We hope that by sharing our expertise, resources and technology, we can help to accelerate work that saves lives and expands access to
critical services around the world during this challenging time.”
-- Bob Swan, Intel chief executive officer
What It Funds: Approximately $40 million will fund the Intel COVID-19 Response and Readiness and Online Learning initiatives. The Intel COVID-19 Response and Readiness Initiative will provide funding to accelerate customer and partner advances in diagnosis, treatment and vaccine development, leveraging technologies such as artificial intelligence (AI), high-performance computing and edge-to-cloud service delivery. Through the initiative, Intel will help healthcare and life sciences manufacturers increase the availability of technology and solutions used by hospitals to diagnose and treat COVID-19. It will also support the creation of industry alliances that accelerate worldwide capacity, capability and policy to respond to this and future pandemics, building on Intel’s own experience in driving technology innovation in the health and life sciences arena.
Diesen Artikel teilen
